Skip to main content
Log in

Effects of oral aspartame on plasma phenylalanine in humans and experimental rodents

  • Short Note
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

All aspartame does given to humans cause greater elevations in plasma (and, presumably, brain) phenylalanine than in plasma tyrosine. In contrast, doses of aspartame usually used in experiments on rodents preferentially elevate tyrosine. Since phenylalanine can inhibit brain catecholamine synthesis while tyrosine is the antidote for this effect, we determined the aspartame dose that would be needed to elevate phenylalanine more than tyrosine in rodents, using published data. In general rodents need 60 times as much aspartame, on a mg/kg basis, as humans to obtain comparable elevations in phenylalanine with respect to tyrosine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bradstock MK, Serdula MK, Marks JS, Barnard RJ, Crane NT, Remmington PL, Trowbridge FL (1986) Evaluation of reactions to food additives: the aspartame experience. Am J Clin Nutr 43: 464–469

    PubMed  Google Scholar 

  • Caballero B, Mahon B, Rohr F, Levy HL, Wurtman RJ (1986) Plasma amino acid levels after single dose aspartame consumption in phenylketonuria. J Pediatr 109: 669–671

    Google Scholar 

  • Department of Health and Human Services. Quarterly Report on adverse reactions associated with aspartame ingestion. October 1, 1986

  • Drake ME (1986) Panic attacks and excessive aspartame ingestion. Lancet ii: 631

    Google Scholar 

  • Garratini S (1986) Aspartame, brain monoamines and neurochemical mediators. International Aspartame Workshop, Nov. 17–21, 1986, Marbella, Spain

  • Johns D (1986) Migraine provoked by aspartame. N Engl J Med 315: 456

    Google Scholar 

  • Kiritsy PJ, Maher TJ (1986) Acute effects of aspartame on systolic blood pressure in spontaneously hypertensive rats. J Neural Transm 66: 121–128

    PubMed  Google Scholar 

  • Maher TJ, Pinto JMB (1987) Aspartame administration potentiates fluorothyl-induced seizures in mice. J Neurochem 48: S52

    Google Scholar 

  • Milner JD, Wurtman RJ (1985) Tyrosine availability determines stimulus-evoked dopamine release from rat striatal slices. Neurosci Lett 59: 215–220

    PubMed  Google Scholar 

  • Milner JD, Irie K, Wurtman RJ (1986) Effects of phenylalanine on the release of endogenous dopamine from rat striatal slices of endogenous dopamine from rat striatal slices. J Neurochem 47: 1444–1448

    PubMed  Google Scholar 

  • Pardridge WM (1986) Potential effects of the dipeptide sweetener aspartame on the brain. In: Wurtman RJ, Wurtman JJ (eds) Nutrition and the brain. Raven Press, New York 7: 199–241

    Google Scholar 

  • Pinto JMB, Maher TJ (1986) High dose aspartame lowers the seizure threshold to subcutaneous pentylenetetrazole in mice. Pharmacologist 28: 201

    Google Scholar 

  • Stegink LD, Filer LJ jr, Baker GL, McDonnell JE (1979 a) Effect of aspartame loading upon plasma and erythrocyte amino acid levels in phenylketonuric heterozygotes and normal adult subjects. J Nutr 109: 708–717

    PubMed  Google Scholar 

  • Stegink LD, Filer LJ jr, Baker GL (1979 b) Plasma, erythrocyte and human milk levels of free amino acids in lactating women administered aspartame or lactose. J Nutr 109: 2173–2181

    PubMed  Google Scholar 

  • Stegink LD, Filer LJ jr, Baker GL, McDonnell JE (1980) Effect of an abuse dose of aspartame upon plasma and erythrocyte levels of amino acids in phenylketonuric heterozygous and normal adults. J Nutr 110: 2216–2224

    PubMed  Google Scholar 

  • Stegink LD (1984) Aspartame metabolism in humans: acute dosing studies. In: Stegink LD, Filer LJ (eds) Aspartame: physiology and biochemistry. Marcel Dekker, New York, pp 509–553

    Google Scholar 

  • Swaiman KF (1969) The effect of phenylalanine and its metabolites on glucose utilization in developing brain. J Neurochem 16: 385–388

    PubMed  Google Scholar 

  • Wurtman RJ (1983) Neurochemical changes following high-dose aspartame with dietary carbohydrates. N Engl J Med 309: 429–430

    PubMed  Google Scholar 

  • Wurtman RJ (1985) Aspartame: possible effect on seizure susceptibility. Lancet: 1060

  • Yokogoshi H, Roberts CH, Caballero B, Wurtman RJ (1984) Effects of aspartame and glucose administration on brain and plasma levels of large neutral amino acids and brain 5-hydroxyindoles. Am J Clin Nutr 40: 1–7

    PubMed  Google Scholar 

  • Yokogoshi H, Wurtman RJ (1986) Acute effects of oral or parenteral aspartame on catecholamine metabolism in various regions of rat brain. J Nutr 116: 356–364

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wurtman, R.J., Maher, T.J. Effects of oral aspartame on plasma phenylalanine in humans and experimental rodents. J. Neural Transmission 70, 169–173 (1987). https://doi.org/10.1007/BF01252517

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01252517

Key words

Navigation